Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

L. Vasanthamohan; Thomas DeLoughery

doi:10.7326/ACPJC-2018-169-10-052

Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	JC52
Journal	Annals of internal medicine
Volume	169
Issue number	10
DOIs	https://doi.org/10.7326/ACPJC-2018-169-10-052
State	Published - Nov 20 2018

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/ACPJC-2018-169-10-052

Cite this

@article{c7361161ea7c4fb7bee7cd5df1d1b188,

title = "Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy",

author = "L. Vasanthamohan and Thomas DeLoughery",

year = "2018",

month = nov,

day = "20",

doi = "10.7326/ACPJC-2018-169-10-052",

language = "English (US)",

volume = "169",

pages = "JC52",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "10",

}

TY - JOUR

T1 - Review

T2 - In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

AU - Vasanthamohan, L.

AU - DeLoughery, Thomas

PY - 2018/11/20

Y1 - 2018/11/20

UR - http://www.scopus.com/inward/record.url?scp=85056730580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056730580&partnerID=8YFLogxK

U2 - 10.7326/ACPJC-2018-169-10-052

DO - 10.7326/ACPJC-2018-169-10-052

M3 - Comment/debate

C2 - 30452559

AN - SCOPUS:85056730580

SN - 0003-4819

VL - 169

SP - JC52

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 10

ER -

Review: In VTE, reduced- and full-dose extended DOAC therapies do not differ and are better than no extended therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this